Month: December 2020

PRESS RELEASEDecember 21, 2020Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the further expansion of its executive team with the appointments of Denelle Waynick as Chief Legal Officer and Kyle Haraldsen as Chief Technical Operations Officer. The positions will be based in the U.S. and will support Saniona’s advancement of clinical trials for Tesomet and SAN711 as well as the company’s growing U.S. presence. “This has been a year of transformation for Saniona, evolving from a company focused on early-stage research to one capable of conducting its own mid-stage clinical trials. As we close out 2020, the hiring of Denelle and Kyle completes Saniona’s executive team in support of our current business,” said Rami Levin, President and CEO of Saniona. “As we look to 2021, our entire...

TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (the “Company” or “Platinex“) is pleased to announce that its Annual General Meeting of shareholders was held in Toronto, Ontario on December 15, 2020 at which all of the following resolutions were passed:Setting the number of Directors at six;The re-election of the incumbent directors, being James Trusler, Graham Warren, Lorne Burden, Felix Lee and Greg Ferron;The re-appointment of Baker Tilly WM LLP as auditors of the Company; andThe approval of the Company’s stock option plan.The Company confirms that 41,512,575 shares were voted, representing 28.6% of the outstanding shares and all resolutions passed with over 96% approval.Lori Paradis, Assistant Secretary                 Tel: (416) 268-2682                Email: lparadis@platinex.comWeb:...

Attached is a major shareholder announcement from Eimskipafélag Íslands hf. on behalf of Arion bank.Attachment20201221_Floggun_EIM

Meðfylgjandi er flöggun frá Eimskipafélagi Íslands hf. fyrir hönd Arion banka.Viðhengi20201221_Floggun_EIM

LEXINGTON, Mass. and AMSTERDAM, Dec. 21, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that its hemophilia B gene therapy program, including the pivotal, Phase III HOPE-B study, has been placed on clinical hold by the U.S. Food and Drug Administration (FDA).   Patient dosing is complete in each of uniQure’s three hemophilia B gene therapy studies, and there is no plan to enroll or treat additional patients.The clinical hold was initiated following the submission of a safety report in mid-December relating to a possibly related serious adverse event associated with a preliminary diagnosis of hepatocellular carcinoma (HCC), a form of liver cancer, in one patient in the HOPE-B trial that was treated with...

CALGARY, Alberta, Dec. 21, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) announced today that Corvus Airlines (dba Ravn Alaska), a regional airline that specializes in servicing the small communities in Alaska, has signed an agreement with FLYHT to reactivate its fleet of nine DHC-8 aircraft with full AFIRS™ services. As of November 20th, Ravn Alaska obtained route authority from the US Department of Transportation and has resumed scheduled flights to and from Anchorage, Dutch Harbor (Unalaska), Homer, Kenai, Kodiak, and Sand Point.“The FLYHT team welcomes Ravn back to the Alaskan skies and as a valued customer of FLYHT,” stated Robert Logullo, FLYHT Account Manager. “Ravn Alaska’s quick emergence from Chapter 11 is a sure sign that this essential service needed to...